Back to User profile » Dr Eva Havrdova
Paper published by Dr Eva Havrdova:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
Havrdova E, Cohen JA, Horakova D, Kovarova I, Meluzinova E
Therapeutics and Clinical Risk Management 2017, 13:1423-1437
Published Date: 16 October 2017